Combining CD19 Redirection and Alloanergization to Generate Tumor-Specific Human T Cells for Allogeneic Cell Therapy of B-Cell Malignancies
Cancer Research - United States
doi 10.1158/0008-5472.can-09-3845
Full Text
Open PDFAbstract
Available in full text
Date
April 27, 2010
Authors
Publisher
American Association for Cancer Research (AACR)